National trends in psychostimulant-related deaths: 1999-2009

Substance Abuse

Volumn 34, Issue 2, 2013, Pages 129-136

  Calcaterra, Susan ^a,b   Binswanger, Ingrid A ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Amphetamine; methamphetamine; overdose; psychostimulant

Indexed keywords

CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; DRUG OVERDOSE; FACTUAL DATABASE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; RACE; RISK FACTOR; SEXUAL DEVELOPMENT; STATISTICS; TOPOGRAPHY; UNITED STATES; ANCESTRY GROUP; EPIDEMIOLOGY; STATISTICS AND NUMERICAL DATA; TRENDS;

ADOLESCENT; ADULT; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM STIMULANTS; CONTINENTAL POPULATION GROUPS; DATABASES, FACTUAL; DRUG OVERDOSE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX CHARACTERISTICS; TOPOGRAPHY, MEDICAL; UNITED STATES;

EID: 84876379340     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2012.726959     Document Type: Article

References (39)

1. National Drug Threat Assessment 2010. US Department of Justice, National Drug Intelligence Center United States; February 2010. Available at: http://www.justice.gov/ndic/pubs38/38661/. Accessed January 2012.
2. Substance Abuse and Mental Health Services Administration. Results From the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2010. NSDUH Series H-38A, HHS Publication No. SMA 10-4856. Available at: http://www.samhsa.gov/data/NSDUH/ 2k9NSDUH/2k9 Results.htm. Accessed July 2012.
3. Wilens T, Adler L, Adams J, et al.,Misuse and diversion of stimulants prescribed for ADHD: a systemic review of the literature. J Am Acad Child Adolescent Psychiatry. 2008;47:21-31.
4. The Treatment Episode Data Set (TEDS). Available at: http://www. icpsr.umich.edu/icpsrweb/SAMHDA/series/00056. Accessed January 2012.
5. Drug AbuseWarning Network. Available at: http://www.samhsa.gov/data/DAWN. aspx. Accessed January 2012.
6. National Survey on Drug Use and Health. Available at: http://oas.samhsa.gov/nhsda.htm. Accessed January 2012.
7. United States Drug Enforcement Administration. Methamphetamine lab incidents 2004-2010. Available at: http://www.justice.gov/dea/concern/map lab seizures.html. Accessed July 2012.
8. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS) 1997-2007. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2009. DASIS Series: S-47, DHHS Publication No. (SMA) 09-4379. Available at: http://wwwdasis.samhsa.gov/teds07/ teds2k7a508web.pdf. Accessed January 2012.
9. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Emergency Department Trends From Drug Abuse Warning Network, Final Estimates 1995-2002. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2003. DHHS Publication No. SMA 03-3780, DAWN Series D-24.Available at: http://www.samhsa.gov/data/driverrprt/dawn2k2/2k4 amphetamines.pdf. Accessed January 2012.
10. Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network. 2009: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011; HHS Publication No. (SMA) 11-4659, DAWN Series D-35. Available at: http://www. samhsa.gov/data/2k11/dawn/2k9dawned/html/dawn2k9ed. htm#Sect1. 2. Accessed July 2012.
11. Salo R, Flower K, Kielstein A, et al., Psychiatric comorbidity in methamphetamine dependence. Psychiatry Res. 2011;186:356-361.
12. Rounsaville B. Treatment of cocaine dependence and depression. Biol Psychiatry. 2004;56:803-809.
13. World Health Organization. International Classification of Diseases. Available at: http://www.who.int/classifications/icd/en/. Accessed January 2012.
14. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS): 1996-2006. Available at: http://wwwdasis.samhsa.gov/teds06/teds2k6aweb508. pdf. Accessed January 2012.
15. Darke S, Kaye S, McKetin R, et al. Major physical and psychological harms of methamphetamine. Drug Alcohol Rev. 2008;27:253-262.
16. Combat Methamphetamine Epidemic Act 2005 (Title VII of Public Law 109-177). USA Patriot Improvement and Reauthorization Act of 2005. Available at: http://www.deadiversion.usdoj.gov/meth/pl109 177.pdf
17. Dluzen D, Liu B. Gender differences in methamphetamine use and responses: a review. Gender Med. 2008;5:24-35.
18. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (January 26, 2007). The NSDUH Report: Methamphetamine Use. Rockville, MD. Available at: http://www. samhsa.gov/data/2k7/meth/meth.pdf. Accessed January 2012.
19. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (August 24, 2010). The DAWN Report: Emergency Department Visits Involving Methamphetamine: 2004 to 2008. Rockville, MD. Available at: http://oas.samhsa.gov/2k10/DAWN017/Meth.htm. Accessed January 2012.
20. Substance Abuse and Mental Health Services Administration. Results From the 2007 National Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2008. NSDUH Series H-34, DHHS Publication No. SMA 08-4343. Available at: http://www.samhsa.gov/data/nsduh/2k7nsduh/2k7Results.htm. Accessed January 2012.
21. Barlow A, Mullany B, Neault N, et al. Examining correlates of methamphetamine and other drug use in pregnant American Indian adolescents.AmIndian Alaska Native Ment Health Res. 2010;17:1-24.
22. National Drug Intelligence Center, US Department of Justice. Indian Country Drug Threat Assessment. Washington, DC: US Department of Justice; 2008. Document ID 2008-RO958-002. Available at: http://www.justice.gov/ndic/pubs28/ 29239/index.htm. Accessed January 2012.
23. Oversight Hearing on the Problem of Methamphetamine in Indian Country. Testimony of Jefferson Keel, First Vice President, National Congress of American Indians. United States Senate Committee on Indian Affairs. Available at: http://www.indian.senate.gov/public/files/Keel040506.pdf. Accessed January 2012.
24. National Methamphetamine Initiative Survey: the status of the methamphetamine threat and impact on Indian Lands. Prepared for Bureau of Indian Affairs Law Enforcement Services. April 12, 2006. Available at: http://www.ncai.org/ncai/Meth/BIA MethSurvey.pdf. Accessed January 2012.
25. Katz R. Addressing the health care needs of American Indians and Alaska Natives. Am J Public Health. 2004;94:13-14.
26. Moulton P,Miller M, Offutt S, et al. Identifying rural health care needs using community conversations. J Rural Health. 2007;23:92-96.
27. Call K, McAlpine D, Johnson P, et al. Barriers to care among American Indians in public health care programs. Med Care. 2006;44:595-600.
28. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. SAS output for TEDS admissions by state and year. Available at: http://wwwdasis.samhsa.gov/webt/NewMapv1. htm. Accessed July 2012.
29. Turnipseed S, Richards J, Kirk J, Diercks D, Amsterdam E. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J EmergMed. 2003;24:369-373.
30. Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction. 2007;102:1204-1211.
31. Diercks D, Fonarow G, Kirk J, et al. Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the acute decompensated heart failure national registry emergency module). Am J Cardiol. 2008;102:1216-1219.
32. Wijetunga M, Seto T, Lindsay J, Schatz I. Crystal methamphetamineassociated cardiomyopathy: tip of the iceberg? J Toxicol. 2003;41:981-986.
33. Yeo K, Wijetunga M, Ito H, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med. 2007;120:165-171.
34. Diercks D, Kirk J, Turnipseed S, Amsterdam E. Evaluation of patients with methamphetamine-and cocaine-related chest pain in a chest pain observation unit. Crit Pathways Cardiol. 2007;6:161-164.
35. McKetin R, McLaren J, Lubman D, et al. The prevalence of psychotic symptoms among methamphetamine users. Addiction. 2006;101:1473-1478.
36. Zweben J, Cohen J, Christian D, et al., Psychiatric symptoms in methamphetamine users. Am J Addict. 2004;13:181-190.
37. Glasner-Edwards S, Marinelli-Casey P, Hillhouse M, et al., Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow up. 2009;197:225-231.
38. Yen CF, Chong MY. Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study. Compr Psychiatry. 2006;47:215-220.
39. US Department of Justice National Drug Intelligence Center. NationalMethamphetamine Threat Assessment 2010. Product No. 2010-Q0317-004. Available at: http://s3.amazonaws.com/nytdocs/docs/374/374.pdf. Accessed July 2012.